PHI with Large plaque parapsoriasis
How does this condition affect your private health insurance?
Großfleckige Parapsoriasis en plaques, also known as large plaque parapsoriasis, is a rare, chronic inflammatory skin disorder. It manifests as persistent, well-demarcated, erythematous-squamous plaques, typically exceeding 5 cm in diameter, predominantly on the trunk and proximal extremities. Lesions are often asymptomatic or mildly itchy. Histologically, it shows features resembling chronic dermatitis but with subtle atypical lymphocytes. This condition is considered a low-grade cutaneous T-cell lymphoma or a pre-malignant state. A significant proportion of cases may progress to mycosis fungoides, a type of skin lymphoma, over several years, necessitating careful monitoring and regular dermatological follow-up.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 30%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Months to years for initial plaque persistence.
Duration of Illness (Lifetime)
Chronic, lifelong, often with potential for progression.
Cost of Treatment (Initial)
Moderate (diagnostic tests, topical treatments, initial phototherapy sessions).
Cost of Treatment (Lifetime)
High (chronic management, regular follow-ups, potential advanced therapies for progression to lymphoma).
Mortality Rate
Very low directly; increases significantly if it progresses to advanced Mycosis Fungoides.
Risk of Secondary Damages
Moderate (skin changes, psychological distress, potential for disfigurement; higher with progression to Mycosis Fungoides).
Probability of Full Recovery
Low (spontaneous complete remission is rare; persistent lesions are characteristic).
Underlying Disease Risk
Low (not typically associated with other systemic diseases, but it is considered a precursor to Mycosis Fungoides).